S
BIVI icon

swisspartners’s BioVie BIVI Stock Holding History

swisspartners’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.29M Buy
2,943
+1,333
+83% +$721K 2.92% 10
2022
Q3 		$401K Hold
1,610
– – 0.42% 45
2022
Q2 		$241K Buy
1,610
+805
+100% +$242K 0.23% 63
2022
Q1 		$380K Hold
805
– – 0.3% 58
2021
Q4 		$367K Hold
805
– – 0.26% 66
2021
Q3 		$542K Buy
805
+250
+45% +$268K 0.42% 50
2021
Q2 		$941K Buy
555
+12
+2% +$18.7K 0.67% 41
2021
Q1 		$1.05M Sell
543
-207
-28% -$590K 0.85% 30
2020
Q4 		$1.28M Buy
+750
New +$749K 1.12% 25

Other funds holding BIVI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

swisspartners's BIVI Position: Q4 2022 in Review

swisspartners increased its BioVie (BIVI) stake by 83% in Q4 2022, buying an estimated $721K and bringing the position to 2,943 shares worth $2.29M. The position accounts for 2.92% of the portfolio, ranked #10.

swisspartners first reported a position in BIVI in Q4 2020 and has held it in 9 quarters since. 39 funds tracked by Wall St. Rank hold BIVI as of Q4 2022.

  • swisspartners held 2,943 shares of BioVie worth $2.29M as of Q4 2022.
  • swisspartners bought 1,333 BioVie shares in Q4 2022, an estimated $721K.
  • BioVie made up 2.92% of swisspartners's portfolio in Q4 2022, its #10 holding.
  • swisspartners first reported a position in BioVie in Q4 2020 and has held it in 9 quarters since.
  • 39 funds tracked by Wall St. Rank held BioVie as of Q4 2022.

Based on swisspartners's 13F filing for Q4 2022, filed 14 Feb 2023.